In 2000 was created Insulet, which is appeared as Corporate Investor. The main department of described Corporate Investor is located in the Bedford. The fund was located in North America if to be more exact in United States.
The top activity for fund was in 2017. The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 investment rounds annually.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight Glooko. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. We can highlight the next thriving fund investment areas, such as Software, Mobile Apps.
The usual cause for the fund is to invest in rounds with 7 partakers. Despite the Insulet, startups are often financed by Social Capital, Samsung NEXT, Canaan Partners. The meaningful sponsors for the fund in investment in the same round are Social Capital, Samsung NEXT, Medtronic.
Related Funds
Fund Name | Location |
14th Street Global Ventures | - |
Billiken Angels Network | Missouri, St Louis, United States |
Covidien | County Dublin, Dublin, Ireland |
CPMG | Dallas, Texas, United States |
Ernst Gohner Stiftung | Cham, Switzerland, Zug |
Hangzhou Lianchuang Investment | China, Hangzhou, Zhejiang |
IPV Capital | China, Shanghai |
Kokusai Kogyo | Japan, Tokyo |
Life Science Venture Capital Management | - |
MCM Investment Partners | - |
Navare Invest | - |
Neu Venture Capital | New York, New York, United States |
Patagonia Ventures | Argentina, Buenos Aires, Distrito Federal |
SKS Capital | California, Los Altos Hills, United States |
Start-Up Brasil | Brazil, São Paulo, Sao Paulo |
Startupbootcamp Fintech New York | New York, New York, United States |
Surya Ventures Pte Ltd | Central, Central Region, Singapore |
UJ Ventures | California, Los Altos, United States |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Glooko | $35M | 27 Jun 2017 | Mountain View, California, United States |
– Glooko, a leading provider of remote patient monitoring and chronic care management solutions including diabetes and obesity, has raised a $30m Series D round of funding.
– The financing was led by Health Catalyst Capital along with participation from existing investors Canaan Partners, Georgian, Novo Nordisk, Insulet and Mayo Clinic.
– Proceeds will be used to accelerate organic growth and strategic initiatives across the company’s broad and growing product line of advanced digital health solutions.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Glooko | $35M | 27 Jun 2017 | Mountain View, California, United States |